Piedmont Investment Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-15,220
Closed -$2.24M 553
2020
Q1
$2.24M Buy
15,220
+1,917
+14% +$305K 0.09% 189
2019
Q4
$2.06M Buy
13,303
+578
+5% +$83.3K 0.07% 210
2019
Q3
$1.72M Buy
12,725
+168
+1% +$22K 0.07% 215
2019
Q2
$1.53M Sell
12,557
-1
-0% -$111 0.06% 236
2019
Q1
$1.31M Buy
12,558
+279
+2% +$28.8K 0.05% 257
2018
Q4
$1.4M Buy
12,279
+672
+6% +$72K 0.07% 230
2018
Q3
$1.34M Buy
11,607
+9,992
+619% +$1.09M 0.06% 255
2018
Q2
$167K Buy
+1,615
New +$163K 0.01% 913
2016
Q3
Sell
-16
Closed -$1.01K 676
2016
Q2
$1.01K Buy
+16
New +$943 ﹤0.01% 371
2014
Q1
Sell
-447,545
Closed -$21.1M 342
2013
Q4
$21.1M Buy
447,545
+151,776
+51% +$7.68M 1.13% 42
2013
Q3
$15.6M Buy
+295,769
New +$14.3M 0.82% 41

Other funds holding RMD

Piedmont Investment Advisors's RMD Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of ResMed (RMD) in Q2 2020, closing a stake of 15,220 shares — an estimated $2.24M sold.

Piedmont Investment Advisors first reported a position in RMD in Q3 2013 and held it in 11 quarters. The position peaked at $21.1M in Q4 2013. 582 funds tracked by Wall St. Rank hold RMD as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining ResMed position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 15,220 ResMed shares in Q2 2020, an estimated $2.24M.
  • Piedmont Investment Advisors first reported a position in ResMed in Q3 2013 and held it in 11 quarters.
  • Piedmont Investment Advisors's ResMed position peaked at $21.1M in Q4 2013.
  • 582 funds tracked by Wall St. Rank held ResMed as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.